Literature DB >> 24989023

IgE deficiency may indicate underlying hypogammaglobulinaemia?

Shireen McVicker, M Yousuf Karim.   

Abstract

Low serum immunoglobulin E (IgE) (<2 kU/L) found during allergy investigations may be a marker for other immunodeficiency states, in particular common variable immunodeficiency. The latter is characterised by recurrent infections, mainly respiratory, resulting in structural lung damage making early diagnosis important. We looked through 4013 samples retrospectively over a 12-month period to identify samples with IgE<2 kU/L. We identified 74/4013 (1.84%) with serum IgE levels<2 kU/L. Only 20 samples had serum immunoglobulin quantification and serum electrophoresis requested. Three of these samples were from the same patient, 10/18 (56%) had one or more classes of immunoglobulin above/below reference range for age and two of these had new diagnosis of immunodeficiency. Serum IgE<2 kU/L can be a marker for hypogammaglobulinaemia or common variable immunodeficiency. As early diagnosis is important to reduce morbidity and mortality, very low serum IgE should trigger further investigation—that is, serum protein electrophoresis and immunoglobulin quantification.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24989023     DOI: 10.1136/jclinpath-2014-202461

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  3 in total

Review 1.  Reflex Testing of Immunoglobulins in Patients with Total Serum IgE < 2 kU/L.

Authors:  Lisa Campisi; Tamara Forster; Mohammed Yousuf Karim
Journal:  J Clin Immunol       Date:  2018-06-29       Impact factor: 8.317

2.  Low immunoglobulin E flags two distinct types of immune dysregulation.

Authors:  M Elkuch; V Greiff; C T Berger; M Bouchenaki; T Daikeler; A Bircher; A A Navarini; I Heijnen; M Recher
Journal:  Clin Exp Immunol       Date:  2017-01-11       Impact factor: 4.330

3.  Factors associated with IgG levels in adults with IgG subclass deficiency.

Authors:  James C Barton; Jackson Clayborn Barton; Luigi F Bertoli; Ronald T Acton
Journal:  BMC Immunol       Date:  2021-08-09       Impact factor: 3.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.